META · NASDAQ-GS
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $200.97B | $164.50B | $134.90B | $116.61B | $117.93B | $85.97B | $70.70B | $55.84B |
| Cost of Revenue | $36.17B | $30.16B | $25.96B | $25.25B | $22.65B | $16.69B | $12.77B | $9.36B |
| Research & Development | $57.37B | $43.87B | $38.48B | $35.34B | $24.66B | $18.45B | $13.60B | $10.27B |
| Selling, General & Administrative | $12.15B | $9.74B | $11.41B | $11.82B | $9.83B | $6.56B | $10.46B | $3.45B |
| Operating Expenses | $117.69B | $95.12B | $88.15B | $87.67B | $71.18B | $53.29B | $46.71B | $30.93B |
| Operating Income | $83.28B | $69.38B | $46.75B | $28.94B | $46.75B | $32.67B | $23.99B | $24.91B |
| Interest Expense | $1.09B | $683.00M | $446.00M | $185.00M | $23.00M | — | $20.00M | $9.00M |
| Other Income / (Expense) | $2.66B | $1.28B | $677.00M | -$125.00M | $531.00M | $509.00M | $826.00M | $448.00M |
| Income Before Taxes | $85.93B | $70.66B | $47.43B | $28.82B | $47.28B | $33.18B | $24.81B | $25.36B |
| Provision for Income Taxes | $25.47B | $8.30B | $8.33B | $5.62B | $7.91B | $4.03B | $6.33B | $3.25B |
| Net Income | $60.46B | $62.36B | $39.10B | $23.20B | $39.37B | $29.15B | $18.48B | $22.11B |
| Basic EPS | $23.98 | $24.61 | $15.19 | $8.63 | $13.99 | $10.22 | $6.48 | $7.65 |
| Diluted EPS | $23.49 | $23.86 | $14.87 | $8.59 | $13.77 | $10.09 | $6.43 | $7.57 |
| Basic Shares Outstanding | 2.52B | 2.53B | 2.57B | 2.69B | 2.81B | 2.85B | 2.85B | 2.89B |
| Diluted Shares Outstanding | 2.57B | 2.61B | 2.63B | 2.70B | 2.86B | 2.89B | 2.88B | 2.92B |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $28.84 | $27.56 | $32.53 | 12 | ↑3 ↓7 |
| Dec 2027 | $34.54 | $31.30 | $38.26 | 18 | ↑4 ↓10 |
| Dec 2028 | $38.96 | $32.20 | $46.67 | 9 | ↑3 ↓4 |
| Dec 2029 | $55.09 | $55.09 | $55.09 | 1 | ↑0 ↓0 |